Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?

Staying Ahead with Company Updates and Product Innovations. Read the news from PerfectClean, the FDA, and the CDC.

Noah Wald-Dickler, MD, FACP, discusses the safety and efficacy of oral transition therapy, challenges in antimicrobial stewardship, and evidence-based alternatives presented at SHEA 2024.

Opinion: Kevin Kavanagh, MD, examines a summary of studies on how COVID-19 may damage the brain's frontal lobes, alter personality traits and cognitive functions, and potentially reshape society's dynamics.

Cheri Ackert-Burr, DNP, BAEd, RN, CNOR, CNS, AGTS, discusses optimizing drying strategies for medical devices, crucial in instrument processing, emphasizing efficiency gains and insights shared at the HSPA Annual Conference.

A struggling infection preventionist seeks guidance on combatting monotony and finding fulfillment in their role amidst recurring challenges.